Indu G. Rajapaksha
Heidelberg, VIC, Australia
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Mas-related G protein-coupled receptor type D antagonism improves portal hypertension in cirrhotic rats.
Journal: Hepatology communications
Published: October 04, 2021
Angiotensin Converting Enzyme-2 Therapy Improves Liver Fibrosis and Glycemic Control in Diabetic Mice With Fatty Liver.
Journal: Hepatology communications
Published: August 18, 2021
Update on New Aspects of the Renin-Angiotensin System in Hepatic Fibrosis and Portal Hypertension: Implications for Novel Therapeutic Options.
Journal: Journal of clinical medicine
Published: December 28, 2020
Liver-Targeted Angiotensin Converting Enzyme 2 Therapy Inhibits Chronic Biliary Fibrosis in Multiple Drug-Resistant Gene 2-Knockout Mice.
Journal: Hepatology communications
Published: January 30, 2019
The Effects of Diabetes and High-Fat Diet on Polymodal Nociceptor and Cold Thermoreceptor Nerve Terminal Endings in the Corneal Epithelium.
Journal: Investigative ophthalmology & visual science
Published: January 15, 2019
Current therapies and novel approaches for biliary diseases.
Journal: World journal of gastrointestinal pathophysiology
Published: August 09, 2018
The small molecule drug diminazene aceturate inhibits liver injury and biliary fibrosis in mice.
Journal: Scientific reports
Published: January 29, 2018
The Adeno-associated Virus - A Safe and Promising Vehicle for Liverspecific Gene Therapy of Inherited and Non-inherited Disorders.
Journal: Current gene therapy
Published: January 13, 2017
Showing 1-9 of 9
Last Updated: 09/26/2026